Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Myriad Genetics Inc. (MYGN)

13.04   0.3 (2.35%) 10-01 08:53
Open: 12.87 Pre. Close: 12.74
High: 13.23 Low: 12.805
Volume: 704,183 Market Cap: 974M
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. The company is headquartered in Salt Lake City, Utah and currently employs 2,600 full-time employees. The firm is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The firm operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to drug therapy and guide a patient's dosing to enable optimal treatment, or assess a patient's risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services, such as finance, human resources, legal and information technology. Its molecular diagnostic tests include myRisk Hereditary Cancer, BRACAnalysis CDx and COLARIS.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.781 - 12.826 12.826 - 12.867
Low: 12.252 - 12.31 12.31 - 12.362
Close: 12.648 - 12.729 12.729 - 12.803

Technical analysis

as of: 2020-09-30 4:44:22 PM
Overall:       
Stoxline posted a STRONG BUY today, same as yesterday. Upward movement continues.
Target: Six months: 15.68     One year: 16.89
Support: Support1: 11.76    Support2: 9.78
Resistance: Resistance1: 13.43    Resistance2: 14.46
Pivot: 12.82
Moving Average: MA(5): 12.40     MA(20): 12.84
MA(100): 13.11     MA(250): 18.82
MACD: MACD(12,26): -0.19     Signal(9): -0.14
Stochastic oscillator: %K(14,3): 38.61     %D(3): 28.89
RSI: RSI(14): 48.21
52-week: High: 35.29  Low: 9.24  Change(%): -54.7
Average Vol(K): 3-Month: 77227  10-Days: 67370

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
MYGN has closed above bottom band by 45.2%. Bollinger Bands are 33.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 24 Sep 2020
Myriad Genetics (NASDAQ:MYGN) Lowered to Sell at BidaskClub - MarketBeat

Fri, 18 Sep 2020
$134.62 Million in Sales Expected for Myriad Genetics, Inc. (NASDAQ:MYGN) This Quarter - MarketBeat

Sat, 12 Sep 2020
Myriad (MYGN) Down 0.7% Since Last Earnings Report: Can It Rebound? - Nasdaq

Thu, 10 Sep 2020
Myriad Genetics Expands Board of Directors with New Member - Yahoo Finance

Fri, 04 Sep 2020
The Zacks Analyst Blog Highlights: Medtronic, Abbott Laboratories, Myriad Genetics, Zimmer Biomet and General Electric - Yahoo Finance

Fri, 14 Aug 2020
Myriad Genetics' (MYGN) Q4 Loss Narrower Than Estimated - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 75
Shares Float (M) 70
% Held by Insiders 1.76
% Held by Institutions 107.18
Shares Short (K) 10,730
Shares Short P. Month (K) 10,840

Stock Financials

EPS -2.690
EPS Est This Year 1.030
EPS Est Next Year 1.190
Book Value (p.s.) 12.290
Profit Margin -31.24
Operating Margin -21.11
Return on Assets (ttm) -5.7
Return on Equity (ttm) -19.9
Qtrly Rev. Growth -56.7
Gross Profit (p.s.) 6.070
Sales Per Share 8.566
EBITDA (p.s.) -0.842
Qtrly Earnings Growth
Operating Cash Flow (M) 61
Levered Free Cash Flow (M) 110

Stock Valuations

PE Ratio -4.74
PEG Ratio 1.40
Price to Book value 1.04
Price to Sales 1.49
Price to Cash Flow 15.65

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 2009-01-07
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.